Successes and Opportunities during the Pandemic : Reflections and Revelations from a Vaccine Development Perspective
The Centre of Regulatory Excellence (CoRE) launched an annual lecture series in 2021 in Singapore to honor the memory of the late Professor Sir Alasdair Breckenridge, CoRE's founding Chair, and foster dialogue on global biomedical and regulatory perspectives, challenges, and advances. The 2022 Sir Alasdair Breckenridge Lecture “Success and Opportunities in the Pandemic” was delivered by Dr Penny M Heaton, former CEO of the Bill & Melinda Gates Foundation Research Institute and current Global Therapeutics Lead for Vaccines at Johnson & Johnson. Dr Heaton highlighted key lessons on the importance of trust, collaboration, and transparency in the context of health care and vaccine production..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
|---|---|
| Enthalten in: |
Clinical Pharmacology & Therapeutics - 114(2023), 3, Seite 504-506 |
| Beteiligte Personen: |
Heaton, Penny M. [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 American Society for Clinical Pharmacology and Therapeutics |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1002/cpt.2889 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY015401731 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY015401731 | ||
| 003 | DE-627 | ||
| 005 | 20231111143240.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/cpt.2889 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_CPT_2023_114_3.zip.xml |
| 035 | |a (DE-627)WLY015401731 | ||
| 035 | |a (WILEY)CPT2889 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Heaton, Penny M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successes and Opportunities during the Pandemic |b Reflections and Revelations from a Vaccine Development Perspective |
| 264 | 1 | |c 2023 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 American Society for Clinical Pharmacology and Therapeutics | ||
| 520 | |a The Centre of Regulatory Excellence (CoRE) launched an annual lecture series in 2021 in Singapore to honor the memory of the late Professor Sir Alasdair Breckenridge, CoRE's founding Chair, and foster dialogue on global biomedical and regulatory perspectives, challenges, and advances. The 2022 Sir Alasdair Breckenridge Lecture “Success and Opportunities in the Pandemic” was delivered by Dr Penny M Heaton, former CEO of the Bill & Melinda Gates Foundation Research Institute and current Global Therapeutics Lead for Vaccines at Johnson & Johnson. Dr Heaton highlighted key lessons on the importance of trust, collaboration, and transparency in the context of health care and vaccine production. | ||
| 700 | 1 | |a Palaniappan, Kavitha |4 aut | |
| 700 | 1 | |a Stona, Anne‐Claire |4 aut | |
| 700 | 1 | |a Vogel, Silke |4 aut | |
| 700 | 1 | |a Lim, John C. W. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical Pharmacology & Therapeutics |g 114(2023), 3, Seite 504-506 |w (DE-627)WLY003995666 |x 15326535 |7 nnns |
| 773 | 1 | 8 | |g volume:114 |g year:2023 |g number:3 |g pages:504-506 |g extent:3 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 114 |j 2023 |e 3 |h 504-506 |g 3 | ||